Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
Status:
Recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
This is a randomized, double blind, two arms, placebo controlled, clinical trial to study to
evaluate the the safety and efficacy of Mycobacterium w in combination with standard of care
versus placebo with standard of care for preventing the progression of COVID-19 disease and
for reduction in transfer to ICU in COVID-19 infected patients admitted to the hospital.
Phase:
Phase 3
Details
Lead Sponsor:
Cadila Pharnmaceuticals
Collaborator:
Council of Scientific and Industrial Research, India